You are here

  • Home
  • Archive
  • Volume 103, Issue 7
  • Factors influencing macular atrophy growth rates in neovascular age-related macular degeneration treated with ranibizumab or aflibercept according to an observe-and-plan regimen

Article metrics

Article menu
Download PDFPDF
Clinical science
Factors influencing macular atrophy growth rates in neovascular age-related macular degeneration treated with ranibizumab or aflibercept according to an observe-and-plan regimen

 

Online download statistics by month:

Online download statistics by month: August 2018 to March 2024

AbstractFullPdf
Aug 2018162911
Sep 201859410963
Oct 20183093415
Nov 20181972610
Dec 2018625225
Jan 20195412715
Feb 2019835204
Mar 201994352
Apr 201991773
May 2019940119
Jun 20197224931
Jul 20194757955
Aug 20191553717
Sep 201972265
Oct 201990203
Nov 2019195185
Dec 2019300207
Jan 2020162265
Feb 202064202
Mar 2020127205
Apr 202047181
May 202048212
Jun 202058186
Jul 202084164
Aug 202047144
Sep 202067172
Oct 202058192
Nov 20203933
Dec 20207511
Jan 20211411
Feb 20214700
Mar 20213122
Apr 20212933
May 20211701
Jun 2021322
Jul 2021111
Aug 2021221
Sep 2021322
Oct 20213200
Nov 20212830
Dec 20211911
Jan 20222711
Feb 20223122
Mar 20223022
Apr 20222421
May 20225800
Jun 20223910
Jul 20224273
Aug 20226751
Sep 20225601
Oct 20226700
Nov 20226421
Dec 20221300
Jan 2023711
Feb 20236431
Mar 20231911
Apr 20235900
May 2023700
Jun 2023800
Jul 20232331
Aug 20231310
Sep 20232121
Oct 20232211
Nov 20233821
Dec 20233011
Jan 20243210
Feb 20241400
Mar 20242011
Total10069768332